LCN2 and acute kidney injury: Several urinary biomarkers have been discovered as noninvasive indicators for the prediction and diagnosis of AKI, including kidney injury molecule-1, N-acetyl-beta-D-glucosaminidase [5,6], neutrophil gelatinase-associated lipocalin [7] and liver fatty acid-binding protein [8].